Frontage Holdings Corp
HKEX:1521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jubilant Ingrevia Ltd
NSE:JUBLINGREA
|
IN |
|
Shanghai Nenghui Technology Co Ltd
SZSE:301046
|
CN |
|
Tongling Nonferrous Metals Group Co Ltd
SZSE:000630
|
CN |
Frontage Holdings Corp
Other Assets
Frontage Holdings Corp
Other Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Frontage Holdings Corp
HKEX:1521
|
Other Assets
$187.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Assets
$49.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Assets
$43.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Waters Corp
NYSE:WAT
|
Other Assets
$1.3B
|
CAGR 3-Years
46%
|
CAGR 5-Years
25%
|
CAGR 10-Years
14%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Assets
$4.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Assets
$16.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
37%
|
|
Frontage Holdings Corp
Glance View
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.
See Also
What is Frontage Holdings Corp's Other Assets?
Other Assets
187.7m
USD
Based on the financial report for Dec 31, 2025, Frontage Holdings Corp's Other Assets amounts to 187.7m USD.
What is Frontage Holdings Corp's Other Assets growth rate?
Other Assets CAGR 5Y
50%
Over the last year, the Other Assets growth was 0%. The average annual Other Assets growth rates for Frontage Holdings Corp have been 8% over the past three years , 50% over the past five years .
